88 related articles for article (PubMed ID: 17141785)
1. No change in apolipoprotein AI metabolism when subcutaneous insulin infusion is replaced by intraperitoneal insulin infusion in type 1 diabetic patients.
Duvillard L; Florentin E; Baillot-Rudoni S; Lalanne-Mistrich ML; Brun-Pacaud A; Petit JM; Brun JM; Gambert P; Vergès B
Atherosclerosis; 2007 Oct; 194(2):342-7. PubMed ID: 17141785
[TBL] [Abstract][Full Text] [Related]
2. Comparison of apolipoprotein B100 metabolism between continuous subcutaneous and intraperitoneal insulin therapy in type 1 diabetes.
Duvillard L; Florentin E; Baillot-Rudoni S; Lalanne-Mistrich ML; Brun-Pacaud A; Petit JM; Brun JM; Gambert P; Vergès B
J Clin Endocrinol Metab; 2005 Oct; 90(10):5761-4. PubMed ID: 16091481
[TBL] [Abstract][Full Text] [Related]
3. Chronic hyperinsulinemia does not increase the production rate of high-density lipoprotein apolipoprotein AI: evidence from a kinetic study in patients with insulinoma.
Duvillard L; Florentin E; Pont F; Petit JM; Baillot-Rudoni S; Penfornis A; Vergès B
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2460-5. PubMed ID: 23908245
[TBL] [Abstract][Full Text] [Related]
4. Insulin-mediated glucose disposal in type 1 (insulin-dependent) diabetic subjects treated by continuous subcutaneous or intraperitoneal insulin fusion.
Beylot M; Khalfallah Y; Laville M; Sautot G; Dechaud H; Serusclat P; Berthezene F; Riou JP; Mornex R
Diabete Metab; 1987; 13(4):450-6. PubMed ID: 3315766
[TBL] [Abstract][Full Text] [Related]
5. Improved lipoprotein surface and core lipid composition following intraperitoneal insulin delivery in insulin-dependent diabetes mellitus.
Bagdade JD; Dunn FL
Diabetes Metab; 1996 Dec; 22(6):420-6. PubMed ID: 8985650
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E kinetics: influence of insulin resistance and type 2 diabetes.
Bach-Ngohou K; Ouguerram K; Nazih H; Maugère P; Ripolles-Piquer B; Zaïr Y; Frénais R; Krempf M; Bard JM
Int J Obes Relat Metab Disord; 2002 Nov; 26(11):1451-8. PubMed ID: 12439646
[TBL] [Abstract][Full Text] [Related]
7. Continuous intraperitoneal insulin infusion partly restores the glucagon response to hypoglycaemia in type 1 diabetic patients.
Oskarsson PR; Lins PE; Backman L; Adamson UC
Diabetes Metab; 2000 Apr; 26(2):118-24. PubMed ID: 10804326
[TBL] [Abstract][Full Text] [Related]
8. Effects of intraperitoneal versus subcutaneous insulin administration on lipoprotein metabolism in type I diabetes.
Ruotolo G; Micossi P; Galimberti G; Librenti MC; Petrella G; Marcovina S; Pozza G; Howard BV
Metabolism; 1990 Jun; 39(6):598-604. PubMed ID: 2191189
[TBL] [Abstract][Full Text] [Related]
9. Influence of atorvastatin on apolipoprotein E and AI kinetics in patients with type 2 diabetes.
Bach-Ngohou K; Ouguerram K; Frénais R; Maugère P; Ripolles-Piquer B; Zaïr Y; Krempf M; Bard JM
J Pharmacol Exp Ther; 2005 Oct; 315(1):363-9. PubMed ID: 16014756
[TBL] [Abstract][Full Text] [Related]
10. Continuous subcutaneous insulin infusion fails to correct impaired basal glucose metabolism and impaired insulin sensitivity of adipocytes from patients with type 1 (insulin-dependent) diabetes.
Pedersen O; Hjøllund E; Beck-Nielsen H; Richelsen B; Sørensen NS
Diabetes Res; 1986 Jan; 3(1):17-23. PubMed ID: 3514067
[TBL] [Abstract][Full Text] [Related]
11. High-density lipoprotein apolipoprotein A-I kinetics in obese insulin resistant patients. An in vivo stable isotope study.
Pont F; Duvillard L; Florentin E; Gambert P; Vergès B
Int J Obes Relat Metab Disord; 2002 Sep; 26(9):1151-8. PubMed ID: 12187390
[TBL] [Abstract][Full Text] [Related]
12. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.
Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D
Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727
[TBL] [Abstract][Full Text] [Related]
13. Near normalization of metabolism of IDDM: comparison of continuous subcutaneous (CSII) versus intraperitoneal (CIPII) insulin delivery.
Gooch BR; Abumrad NN; Robinson RP; Crofford OB
Horm Metab Res; 1984 Dec; 16 Suppl 1():190-4. PubMed ID: 6398261
[TBL] [Abstract][Full Text] [Related]
14. Intraperitoneal insulin infusion versus islet transplantation: comparative study in patients with type 1 diabetes.
Vantyghem MC; Marcelli-Tourvieille S; Fermon C; Duhamel A; Raverdy V; Arnalsteen L; Kerr-Conte J; Noel C; Fontaine P; Pattou F
Transplantation; 2009 Jan; 87(1):66-71. PubMed ID: 19136893
[TBL] [Abstract][Full Text] [Related]
15. Insulin kinetics in type I diabetic patients treated by continuous intraperitoneal insulin infusion: influence of anti-insulin antibodies.
Lassmann-Vague V; Belicar P; Alessis C; Raccah D; Vialettes B; Vague P
Diabet Med; 1996 Dec; 13(12):1051-5. PubMed ID: 8973887
[TBL] [Abstract][Full Text] [Related]
16. Safety of insulin glulisine when given by continuous subcutaneous infusion using an external pump in patients with type 1 diabetes.
Hoogma RP; Schumicki D
Horm Metab Res; 2006 Jun; 38(6):429-33. PubMed ID: 16823727
[TBL] [Abstract][Full Text] [Related]
17. A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion.
Liebl A; Hoogma R; Renard E; Geelhoed-Duijvestijn PH; Klein E; Diglas J; Kessler L; Melki V; Diem P; Brun JM; Schaepelynck-Bélicar P; Frei T;
Diabetes Obes Metab; 2009 Nov; 11(11):1001-8. PubMed ID: 19740082
[TBL] [Abstract][Full Text] [Related]
18. No effect of liraglutide on high density lipoprotein apolipoprotein AI kinetics in patients with type 2 diabetes.
Duvillard L; Pais de Barros JP; Rouland A; Simoneau I; Denimal D; Bouillet B; Petit JM; Vergès B
Diabetes Metab; 2024 May; 50(3):101535. PubMed ID: 38653365
[TBL] [Abstract][Full Text] [Related]
19. Glycaemic variability in paediatric patients with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) or multiple daily injections (MDI): a cross-sectional cohort study.
Schreiver C; Jacoby U; Watzer B; Thomas A; Haffner D; Fischer DC
Clin Endocrinol (Oxf); 2013 Nov; 79(5):641-7. PubMed ID: 23134485
[TBL] [Abstract][Full Text] [Related]
20. Comparison of intraperitoneal and subcutaneous insulin administration on insulin sensitivity and serum lipids in type I diabetic patients on continuous ambulatory peritoneal dialysis treatment.
Lahtela JT; Mustonen J; Pasternack A
Clin Sci (Lond); 1995 Apr; 88(4):427-32. PubMed ID: 7789044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
